Page 14 - U.S. Growth Healthcare Stocks

UPDATED May 14, 2024

Discover U.S. Healthcare Growth Stocks that are on the NYSE and NASDAQ. Sorted by forecasted growth, these Healthcare Stocks have higher than expected earnings or sales growth compared to other companies.

351 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

DYNT

Dynatronics
US$0.41-14.4%-46.0%US$2.3mn/aPB0.3xn/an/a

ICU

SeaStar Medical Holding
US$0.39-18.1%-42.7%US$29.5mUS$2.00PE-1.1xn/an/a

NURO

NeuroMetrix
US$4.410.1%-41.4%US$9.0mn/aPS1.5xn/an/a

LIFW

MSP Recovery
US$0.81-8.1%-93.7%US$113.1mn/aPS1.7xn/an/a

AMIX

Autonomix Medical
US$2.70-3.9%n/aUS$50.2mn/aPE-4.8xn/an/a

NIVF

NewGenIvf Group
US$1.2414.3%-88.2%US$15.5mn/an/an/an/a

SYRA

Syra Health
US$1.7315.3%n/aUS$18.8mUS$5.32PS4xn/an/a

NVOS

Novo Integrated Sciences
US$0.586.5%-57.7%US$11.0mn/aPB0.5xn/an/a

EAR

Eargo
US$2.57-2.7%-64.3%US$53.4mn/aPS1.3xn/an/a

EUDA

EUDA Health Holdings
US$2.3232.6%61.1%US$81.4mn/aPS21.7xn/an/a

FONR

FONAR
US$16.45-4.1%-1.6%US$104.8mn/aPE8.6xn/an/a

AKLI

Akili
US$0.459.5%-68.6%US$34.5mn/aPS20.9xS31.1%n/a

LUCY

Innovative Eyewear
US$0.20-14.9%-89.4%US$3.2mUS$1.00PS3xS102.7%n/a

AONC

American Oncology Network
US$3.47-8.7%-66.4%US$123.6mn/aPE-4xn/an/a

NUVO

Holdco Nuvo Group D.G
US$2.22-22.1%-78.6%US$85.2mn/an/an/an/a

HCTI

Healthcare Triangle
US$0.83-35.4%-69.2%US$4.1mn/aPB7.1xn/an/a

IINN

Inspira Technologies Oxy B.H.N
US$2.18-1.4%41.6%US$36.3mUS$13.00PB6.6xn/an/a

SNDA

Sonida Senior Living
US$32.56-0.3%404.8%US$428.9mn/aPS1.8xn/an/a

BIMI

BIMI Holdings
US$1.120.9%36.6%US$15.1mn/aPS1.2xn/an/a

PMD

Psychemedics
US$2.654.7%-46.9%US$14.8mn/aPB2.3xn/a0%

XYLO

Xylo Technologies
US$1.89-1.0%-69.8%US$3.7mn/aPB0.2xn/an/a

MBOT

Microbot Medical
US$0.95-0.4%-21.6%US$13.4mUS$7.00PB3xn/an/a

AIH

Aesthetic Medical International Holdings Group
US$0.5015.2%-45.1%US$22.5mn/aPB3.5xn/an/a

STSS

Sharps Technology
US$0.22-8.4%-77.6%US$3.5mUS$16.00PB0.4xn/an/a
Page 14 of 15
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.